Dementia is a brain degeneration characterized by cognitive-functional decline of the patient and is not considered normal aging but a pathological condition whose probability increases with age. Because the percentage of the population over 65 years old in developed countries (such as Greece) is increasing, by 2050 people with dementia in these countries will triple! Approximately the 85% of dementia is Alzheimer's Disease.
The entry of Artificial Intelligence into our lives would not leave out the modern Medicine. Thus, the company LANGaware has developed Artificial Intelligence models Intelligence that utilizes more than 600 digital biomarkers to help diagnose dementia even in very early stages, perhaps even before the clear appearance of symptoms. This is very important for the patient and for the neurologist because the earlier a therapeutic intervention is performed, the milder the picture of the disease, the slower its progression and the better its control.
Thus, the diagnosis of dementia in very early stages (and beyond) is now based on 3 axles: In the classic neurological examination and the patient's history that are combined with some tests (MMSE, clock test, etc.) that the neurologist. The neurologist may need additional imaging tests (CT or MRI of the brain).
In the online memory-description test that is performed while the patient is looking a computer screen on the neurologist's desk and he is talking to a microphone. This innovative online test is evaluated by Artificial Intelligence (LANGaware company) and within a few minutes - and while the patient is still in the clinic - an e-mail is sent with the results. The analysis has to has to do with the patient's verbal flow, vocabulary and variety of words, the syntactic complexity and sound characteristics of his speech patient.
In blood tests such as the biomarker p-Tau217 which increases even in the early stages of Alzheimer's Disease, but also molecular testing for the ApoE alleles (E2, E3, E4) - the E4 allele is the one that increases the risk of the Disease. Blood tests may not be necessary (or at least both) if the neurologist is certain of the diagnosis, but if If the patient or relatives wish, these can also be done immediately after the end of the examination.
So the examinee will have received in a diagnostic visit - lasting half an hour hour- 2 to 3 medical services that will or will not diagnose dementia. This constitutes a New Era in the diagnosis of the Disease and it would not be possible, in this degree, without Artificial Intelligence and advances in laboratory diagnostic tests.
Example of a result from the online test:
